MAM
CLVS

Morse Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Morse Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$609K Buy
2018
Q1 		$620K Buy
2017
Q4 		$316K Sell
2017
Q3 		$2.38M Buy